The Pfizer earnings and Merck earnings reports were both released this morning (Tuesday), and investors are acting differently to these major pharmaceutical stocks.
Pfizer Inc. (NYSE: PFE) stock was up 1.3% in early trading despite missing earnings per share estimates. Merck shares were down 2% despite topping estimates.